ArticleScience advances2025
Development of a targeted oral pharmacologic duodenal exclusion therapy for the treatment of metabolic diseases.
Taylor L Carlson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it